Cell membrane permeability assays

DO David M. P. De Oliveira
LB Lisa Bohlmann
TC Trent Conroy
FJ Freda E.-C. Jen
AE Arun Everest-Dass
KH Karl A. Hansford
RB Raghu Bolisetti
IE Ibrahim M. El-Deeb
BF Brian M. Forde
MP Minh-Duy Phan
JL Jake A. Lacey
AT Aimee Tan
TR Tania Rivera-Hernandez
SB Stephan Brouwer
NK Nadia Keller
TK Timothy J. Kidd
AC Amanda J. Cork
MB Michelle J. Bauer
GC Gregory M. Cook
MD Mark R. Davies
SB Scott A. Beatson
DP David L. Paterson
AM Alastair G. McEwan
JL Jian Li
MS Mark A. Schembri
MB Mark A. T. Blaskovich
MJ Michael P. Jennings
CM Christopher A. McDevitt
MI Mark von Itzstein
MW Mark J. Walker
ask Ask a question
Favorite

Membrane permeability was measured through N-phenyl-1-naphthylamine (NPN) uptake as previously described (48). Briefly, K. pneumoniae MS6671 was grown to OD600 of 0.5 in CA-MHB. Cells were pelleted, washed, and resuspended in an equal volume of 5 mM Hepes buffer (pH 7.2). The bacterial suspension was then allowed to equilibrate at room temperature for 30 min. Following equilibration, bacterial suspensions were treated with combinations of either PBT2 + NPN or EDTA + NPN. PBT2 was added to a final concentration of 0 to 64 μM, EDTA was added to a final concentration of 2 mM, and NPN was added to a final concentration of 10 μM. Immediately after the addition of PBT2 + NPN or EDTA + NPN, NPN fluorescence was measured every 15 s for up to 3 hours at 37°C using a FLUOstar Omega microplate reader (BMG Labtech, Germany) with the excitation and emission wavelengths set at 355 and 460 nm, respectively. Response curves were determined by subtracting the background fluorescence of each respective treatment in the absence of bacteria. All experiments were done in biological triplicate and measured in technical triplicates.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A